Purchase Order N6809421P6059
- Not listed
- This federal contract award, identified as W81K0024P0074, was made by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The $33,333.33 firm fixed-price purchase order contract is for the delivery of various radiopharmaceuticals, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military personnel at VA medical centers and military treatment facilities. RLS (USA) Inc. is a small...
- This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA) and the Department of Veterans Affairs (VA). The prime contractor is RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company that specializes in providing radiopharmaceuticals and related services to the U.S. federal government. The contract has a ceiling value of $299,975.67 and a completion date of September 30, 2023. It is a delivery order contract with a firm-fixed price...
- This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, was awarded a $1.04M firm fixed-price purchase order by Veterans Integrated Service Network 20 on March 1, 2020, for the supply of radiopharmaceuticals. The contract, which originated from an 8(a) sole source solicitation posted by the Department of Veterans Affairs Puget Sound Medical Center, supports nuclear medicine diagnostic services across the VA healthcare system. Performance of the contract is based in Lake Mary, Florida, with an...
- This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
- This firm-fixed price federal contract award, valued at $425,794.77, was issued by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine diagnostic procedures at VA medical centers and military treatment facilities over a 6-month period ending in July 2024. RLS (USA) Inc. operates a nationwide network of 31 radiopharmacy facilities,...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to foreign-owned, for-profit radiopharmacy RLS USA Inc. The contract, valued at $146,279.55, is for the provision of non-PET radiopharmaceuticals and related supplies to support nuclear medicine services at the VA Palo Alto Health Care System. The original solicitation was a request for quote (RFQ) issued by the VA Network Contracting Office 21 (NCO 21) and did not...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $607,676.91 firm fixed price delivery order contract to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, and technetium-99m, to support nuclear medicine services at the Milwaukee VA Medical Center. This delivery order contract is likely part of a...
- The U.S. Defense Health Agency (DHA) awarded a firm fixed-price purchase order to RLS (USA) Inc., a small business radiopharmacy company, for the supply of radiopharmaceuticals to support the Radiology Department at the Naval Hospital Camp Pendleton in California. The contract has a total ceiling value of $204,216.35 and a period of performance through September 30, 2026. RLS (USA) Inc. previously held multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA)...
The Defense Health Agency awarded a firm fixed-price purchase order contract to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide radiopharmaceuticals. The $200,000.00 contract has a completion date of September 30, 2023 and is designated as a total small business set-aside. RLS USA Inc. is a radiopharmacy that operates 31 facilities across 18 states, providing molecular imaging products and services to federal agencies including the Department of Veterans Affairs and the Defense Health Agency. The company holds several other indefinite delivery and blanket purchase agreement contracts with these agencies to supply radiopharmaceuticals like gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine services at VA medical centers and military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | $100.0k | 11/7/22 | |
| P00003 | Exercise an Option | $0 | 9/22/22 | |
| P00002 | Funding Only Action | $50.0k | 12/20/21 | |
| P00001 | Funding Only Action | $50.0k | 11/9/21 | |
| Not listed | Not listed | $0 | 9/29/21 |